Differential change on depressive symptom factors with antidepressant medication and cognitive behavior therapy for major depressive disorder

Journal of Affective Disorders

Volumn 229, Issue , 2018, Pages 111-119

  Dunlop, Boadie W ^a   Cole, Steven P ^b   Nemeroff, Charles B ^c   Mayberg, Helen S ^a   Craighead, W Edward ^a,d  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Research Design Associates Inc   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d EMORY UNIVERSITY   (United States)

Author keywords

Biomarker; Duloxetine; Escitalopram; Item response theory; Precision medicine; Psychotherapy; Rating scales

Indexed keywords

DULOXETINE; ESCITALOPRAM; ANTIDEPRESSANT AGENT; CITALOPRAM;

ADULT; AGED; APPETITE; ARTICLE; BECK DEPRESSION INVENTORY; COGNITIVE BEHAVIORAL THERAPY; CONTROLLED STUDY; DRUG EFFICACY; FACTOR ANALYSIS; FEMALE; HAMILTON DEPRESSION RATING SCALE; HOPELESSNESS; HUMAN; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; MOOD; PRIORITY JOURNAL; SLEEP; TREATMENT DURATION; TREATMENT OUTCOME; COGNITIVE THERAPY; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PROCEDURES; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY;

ADULT; ANTIDEPRESSIVE AGENTS; CITALOPRAM; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; DULOXETINE HYDROCHLORIDE; FACTOR ANALYSIS, STATISTICAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; TREATMENT OUTCOME;

EID: 85039986235     PISSN: 01650327     EISSN: 15732517     Source Type: Journal    
DOI: 10.1016/j.jad.2017.12.035     Document Type: Article

References (48)

1. American Psychiatric Association, Practice Guideline for the Treatment of Patients with Major Depressive Disorder, third ed., 2010, American Psychiatric Association, Washington D.C.
2. Anand, A., Li, Y., Wang, Y., Gardner, K., Lowe, M.J., Reciprocal effects of antidepressant treatment on activity and connectivity of the mood regulating circuit: an FMRI study. J. Neuropsychiatry Clin. Neurosci. 19 (2007), 274–282.
3. Arbuckle, J.L., Amos (Version 24.0) [Computer Program]. 2014, IBM SPSS, Chicago.
4. Bagby, R.M., Ryder, A.G., Schuller, D.R., Marshall, M.B., The Hamilton Depression Rating Scale: has the gold standard become a lead weight?. Am. J. Psychiatry 161 (2004), 2163–2177.
5. Beck, A.T., Rush, A.J., Shaw, B.F., Emery, G., Cognitive Therapy of Depression. 1979, Guilford, New York.
6. Beck, A.T., Ward, C.H., Mendelson, M., Mock, J., Erbaugh, J., An inventory for measuring depression. Arch. Gen. Psychiatry 4 (1961), 561–571.
7. Beck, A.T., Steer, R.A., Garbin, M.G., Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin. Psychol. Rev. 8 (1988), 77–100.
8. Bentler, P.M., Comparative fit indexes in structural models. Psychol. Bull. 107 (1990), 238–246.
9. Brown, T.A., Confirmatory Factor Analysis for Applied Research. 2015, Guilford, New York.
10. Cai, L., Thissen, D., du Toit, S., 2016. IRTPRO (Version 4.) [Computer Program]. Skokie, IL.
11. Conde-López, V., Chamorro, T.E., Useros-Serrano, E., Critical study of the reliability and validity of Beck's Rating scale for the measurement of depression. Arch. Neurobiol. 39 (1976), 313–338.
12. Craighead, W.E., Dunlop, B.W., Combination psychotherapy and antidepressant medication treatment for depression: for whom, when, and how. Annu. Rev. Psychol. 65 (2014), 267–300.
13. DiMascio, A., Weissman, M.M., Prusoff, B.A., Neu, C., Zwilling, M., Klerman, G.L., Differential symptom reduction by drugs and psychotherapy in acute depression. Arch. Gen. Psychiatry 36 (1979), 1450–1456.
14. Dunlop, B.W., Li, T., Kornstein, S.G., Friedman, E.S., Rothschild, A.J., Ferguson, J., Pederson, R., Ahmed, S., Ninan, P., Keller, M., Correlation between patient and clinician assessments of depression severity in the PREVENT study. Psychiatry Res. 177 (2010), 177–183.
15. Dunlop, B.W., Binder, E.B., Cubells, J.F., Goodman, M.G., Kelley, M.E., Kinkead, B., Kutner, M., Nemeroff, C.B., Newport, D.J., Owens, M.J., Pace, T.W.W., Ritchie, J.C., Aponte-Rivera, V., Westen, D., Craighead, W.E., Mayberg, H.S., Predictors of remission in depression to individual and combined treatments (PReDICT): study protocol for a randomized controlled trial. Trials, 13, 2012, 106.
16. Dunlop, B.W., Kelley, M.E., Aponte-Rivera, V., Kinkead, B., Mletzko-Crowe, T., Ritchie, J.C., Nemeroff, C.B., Craighead, W.E., Mayberg, H.S., Effects of patient preferences on outcomes in the Predictors of Remission in Depression to Individual and Combined Treatments (PReDICT) study. Am. J. Psychiatry 174 (2017), 546–556.
17. Dunlop, B.W., McCabe, B., Eudicone, J.M., Sheehan, J.J., Baker, R.A., How well do clinicians and patients agree on depression treatment outcomes? Implications for personalized medicine. Hum. Psychopharmacol. Clin. Exp. 29 (2014), 528–536.
18. Elkin, I., Shea, M.T., Watkins, J.T., Imber, S.D., Sotsky, S.M., Collins, J.F., Glass, D.R., Pilkonis, P.A., Leber, W.R., Docherty, J.P., Fiester, S.J., Parloff, M.B., National Institute of Mental Health Treatment of Depression Collaborative Research Program. General effectiveness of treatments. Arch. Gen. Psychiatry 46 (1989), 971–982.
19. Endicott, J., Spitzer, R.L., A diagnostic interview. The Schedule for Affective Disorders and Schizophrenia. Arch. Gen. Psychiatry 35 (1978), 837–844.
20. First, M.B., Spitzer, R.L., Gibbon, M., Williams, J.B.W., Structured Clinical Interview for DSM-IV Axis I Disorders-Patient Edition (SCID-I/P, Version2.0). 1995, Biometrics Research Department, New York State Psychiatric Institute, New York.
21. Fournier, J.C., DeRubeis, R.J., Hollon, S.D., Gallop, R., Shelton, R.C., Amsterdam, J.D., Differential change in specific depressive symptoms during antidepressant medication or cognitive therapy. Behav. Res. Ther. 51 (2013), 392–398.
22. Fu, C.H., Williams, S.C., Cleare, A.J., Brammer, M.J., Walsh, N.D., Kim, J., et al. Attenuation of the neural response to sad faces in major depression by antidepressant treatment: a prospective, event-related functional magnetic resonance imaging study. Arch. Gen. Psychiatry 61 (2004), 877–889.
23. Fu, C.H., Williams, S.C., Cleare, A.J., Scott, J., Mitterschiffthaler, M.T., Walsh, N.D., et al. Neural responses to sad facial expressions in major depression following cognitive behavioral therapy. Biol. Psychiatry 64 (2008), 505–512.
24. Hamilton, M., A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960), 56–62.
25. Hu, L.T., Bentler, P.M., Cutoff criteria for fit indexes in covariance structure analysis: conventional criteria versus new alternatives. Struct. Equ. Model. 6 (1999), 1–55.
26. Ilardi, S.S., Craighead, W.E., The relationship between personality pathology and dysfunctional cognitions In previously depressed adults. J. Abnorm. Psychol. 108 (1999), 51–57.
27. Jacobson, N.S., Hollon, S.D., Cognitive-behavior therapy versus pharmacotherapy: now that the jury's returned its verdict, it's time to present the rest of the evidence. J. Consult. Clin. Psychol. 64 (1996), 74–80.
28. Kazdin, A.E., Mediators and mechanisms of change in psychotherapy research. Annu. Rev. Clin. Psychol. 3 (2007), 1–27.
29. Keller, M.B., McCullough, J.P., Klein, D.N., Arnow, B., Dunner, D.L., Gelenberg, A.J., Markowitz, J.C., Nemeroff, C.B., Russell, J.M., Thase, M.E., Trivedi, M.H., Zajecka, J., A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression. N. Engl. J. Med. 342 (2000), 1462–1470.
30. Keedwell, P., Drapier, D., Surguladze, S., Giampietro, V., Brammer, M., Phillips, M., Neural markers of symptomatic improvement during antidepressant therapy in severe depression: subgenual cingulate and visual cortical responses to sad, but not happy, facial stimuli are correlated with changes in symptom score. J. Psychopharmacol. 23 (2009), 775–788.
31. Imber, S.D., Pilkonis, P.A., Sotsky, S.M., Elkin, I., Watkins, J.T., Collins, J.F., Shea, M.T., Leber, W.R., Glass, D.R., Mode-specific effects among three treatments for depression. J. Consult. Clin. Psychol. 58 (1990), 352–359.
32. Lux, V., Kendler, K.S., Deconstructing major depression: a validation study of the DSM-IV symptomatic criteria. Psychol. Med. 40 (2010), 1679–1690.
33. Montgomery, S.A., Åsberg, M., A new depression scale designed to be sensitive to change. Br. J. Psychiatry 134 (1979), 382–389.
34. O'Connor, B.P., SPSS and SAS programs for determining the number of components using parallel analysis of Velicer's MAP test. Behav. Res. Methods Instrum. Comput. 32 (2000), 396–402.
35. Rector, N.A., Bagby, R.M., Segal, Z.V., Joffe, R.T., Levitt, A., Self-criticism and dependency in depressed patients treated with cognitive therapy or pharmacotherapy. Cogn. Ther. Res. 24 (2000), 571–584.
36. Ritchey, M., Dolcos, F., Eddington, K.M., Strauman, T.J., Cabeza, R., Neural correlates of emotional processing in depression: changes with cognitive behavioral therapy and predictors of treatment response. J. Psychiatr. Res. 45 (2011), 577–587.
37. Roiser, J.P., Elliott, R., Sahakian, B.J., Cognitive mechanisms of treatment in depression. Neuropsychopharmacol. Rev. 37 (2012), 117–136.
38. Sheline, Y.I., Barch, D.M., Donnelly, J.M., Ollinger, J.M., Snyder, A.Z., Mintun, M.A., Increased amygdala response to masked emotional faces in depressed subjects resolves with antidepressant treatment: an fMRI study. Biol. Psychiatry 50 (2001), 651–658.
39. Stewart, J.G., Harkness, K.L., Symptom specificity in the acute treatment of major depressive disorder: a re-analysis of the treatment of depression collaborative research program. J. Affect. Disord. 137 (2012), 87–97.
40. Tabachnick, B.G., Fidell, L.S., Using Multivariate Statistics. 2014, Pearson, London.
41. Uher, R., Farmer, A., Maier, W., Rietschel, M., Hauser, J., Marusic, A., Mors, O., Elkin, A., Williamson, R.J., Schmael, C., Henigsberg, N., Perez, J., Mendlewicz, J., Janzing, J.G., Zobel, A., Skibinska, M., Kozel, D., Stamp, A.S., Bajs, M., Placentino, A., Barreto, M., McGuffin, P., Aitchison, K.J., Measuring depression: comparison and integration of three scales in the GENDEP study. Psychol. Med. 38 (2008), 289–300.
42. Uher, R., Maier, W., Hauser, J., Marusic, A., Schmael, C., Mors, O., Henigsberg, N., Souery, D., Placentino, A., Rietschel, M., Zobel, A., Dmitrzak-Weglarz, M., Petrovic, A., Jorgensen, L., Kalember, P., Giovannini, C., Barreto, M., Elkin, A., Landau, S., Farmer, A., Aitchison, K.J., McGuffin, P., Differential efficacy of escitalopram and nortriptyline on dimensional measures of depression. Br. J. Psychiatry 194 (2009), 252–259.
43. Uher, R., Perlis, R.H., Placentino, A., Dernovšek, M.Z., Henigsberg, N., Mors, O., Maier, W., McGuffin, P., Farmer, A., Self-report and clinician-rated measures of depression severity: can one replace the other?. Depress. Anxiety 29 (2012), 1043–1049.
44. Weitz, E., Hollon, S.D., Twisk, J., van Straten, A., David, D., DeRubeis, R.J., Dimidjian, S., Dunlop, B.W., Faramarzi, M., Hegerl, U., Jarrett, R.B., Kheirkhah, F., Kennedy, S.J., Mergl, R., Miranda, J., Mohr, D.C., Rush, A.J., Segal, Z.V., Siddique, J., Simmons, A.D., Vittengl, J.R., Cuijpers, P., Does baseline depression severity moderate outcomes between CBT and pharmacotherapy? An individual participant data meta-analysis. JAMA Psychiatry 72 (2015), 1102–1109.
45. Warren, M.B., Pringle, A., Harmer, C.J., A neurocognitive model for understanding treatment action in depression. Philos. Trans. R. Soc. B, 370(1677), 2015, 20140213.
46. Whisman, M.A., The importance of the cognitive theory of change in cognitive therapy of depression. Clin. Psychol. Sci. Pract. 6 (1999), 300–304.
47. Williams, J.B., A structured interview guide for the Hamilton depression Rating. Arch. Gen. Psychiatry 45 (1989), 742–747 (Spanish translation, Jan 2009, obtained from author).
48. Williams, J.B.W., Kobak, K.A., Development and reliability of the SIGMA: a structured interview guide for the Montgomery-Asberg Depression Rating Scale (MADRS). Br. J. Psychiatry 192 (2008), 52–58 (Spanish translation, Jan 2009, obtained from author).